Target: Stroke鈩� Publications
Martin Ebinger, MD; Benjamin Winter, MD; Matthias Wendt, MD; Joachim E. Weber, MD; Carolin Waldschmidt, MD; Michal Rozanski, MD; Alexander Kunz, MD; Peter Koch, MD; Philipp A. Kellner, MD; Daniel Gierhake, MD; Kersten Villringer, MD; Jochen B. Fiebach, MD; Ulrike Grittner, PhD; Andreas Hartmann, MD; Bruno-Marcel Mackert, MD; Matthias Endres, MD; Heinrich J. Audebert, MD
This study, published in the Journal of the American Medical Association (JAMA), shows that Target: Stroke results in faster, appropriate treatment for stroke patients 鈥� ultimately translating to improved patients outcomes, including fewer deaths and less disability.
Initially presented at the International Stroke Conference in February 2013, the study found there was a significant increase in the number of eligible stroke patients receiving timely tPA treatment among Target: Stroke hospitals. The average door-to-needle time dropped from 77 minutes before the initiative was implemented in 2010 to 59 minutes by the end of the study period. More importantly, in-hospital deaths among treated patients dropped 2 percent, and more patients were able to recover at home rather than being transferred to a nursing or rehab facility.
Additionally, the study was recognized by the 蜜芽传媒/American Stroke Association as one of the top advances in heart disease and stroke research in 2014 and was widely covered by national media, including , and
Gregg C. Fonarow, MD; Eric E. Smith, MD, MPH; Jeffrey L. Saver, MD; Mathew J. Reeves, PhD; Adrian F. Hernandez, MD, MHS; Eric D. Peterson, MD, MPH; Ralph L. Sacco, MD; Lee H. Schwamm, MD
The article describes the design and rationale of Target: Stroke.
